Dyne Therapeutics Inc
DYN
Insider trades and stock quote 2024-2026
All insider trades at Dyne Therapeutics Inc
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
10/2/2026
|
Buy |
Posner, Brian S. |
Director |
$16.0 |
$40,000 |
|
9/8/2026
|
Sell |
Cox, John |
CEO & President |
$18.9 |
$106,823 |
|
9/8/2026
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$18.9 |
$24,355 |
|
9/8/2026
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$18.9 |
$3,493 |
|
9/4/2026
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$24.4 |
$91,191 |
|
9/4/2026
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$24.4 |
$21,915 |
|
8/14/2026
|
Sell |
Rhodes, Jason P. |
Director |
$25.0 |
$54,012,900 |
|
8/13/2026
|
Sell |
Cox, John |
CEO & President |
$26.3 |
$131,032 |
|
8/13/2026
|
Sell |
Rhodes, Jason P. |
Director |
$26.2 |
$11,171,995 |
|
8/13/2026
|
Sell |
Lucera, Erick |
Chief Financial Officer |
$26.3 |
$47,225 |
|
8/13/2026
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$26.3 |
$40,892 |
|
8/13/2026
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$26.3 |
$5,939 |
|
7/27/2026
|
Sell |
Kersten, Dirk |
Director |
$25.8 |
$6,670,770 |
|
7/7/2026
|
Sell |
Rhodes, Jason P. |
Director |
$23.4 |
$6,913,821 |
|
7/6/2026
|
Sell |
Rhodes, Jason P. |
Director |
$22.8 |
$10,944,670 |
|
6/29/2026
|
Sell |
Rhodes, Jason P. |
Director |
$21.1 |
$4,131,327 |
|
6/26/2026
|
Sell |
Rhodes, Jason P. |
Director |
$21.3 |
$6,581,223 |
|
6/25/2026
|
Sell |
Lucera, Erick |
Chief Financial Officer |
$20.4 |
$48,114 |
|
6/25/2026
|
Sell |
Rhodes, Jason P. |
Director |
$21.1 |
$508,510 |
|
6/24/2026
|
Sell |
Rhodes, Jason P. |
Director |
$21.0 |
$2,015,818 |
|
6/23/2026
|
Sell |
Kersten, Dirk |
Director |
$21.2 |
$1,542,349 |
|
6/23/2026
|
Sell |
Rhodes, Jason P. |
Director |
$21.1 |
$3,122,169 |
|
6/22/2026
|
Sell |
Kersten, Dirk |
Director |
$20.6 |
$3,922,263 |
|
6/18/2026
|
Sell |
Kersten, Dirk |
Director |
$20.1 |
$941,373 |
|
6/17/2026
|
Sell |
Kersten, Dirk |
Director |
$20.1 |
$754,316 |
|
6/16/2026
|
Sell |
Cox, John |
CEO & President |
$18.3 |
$49,179 |
|
6/16/2026
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$18.3 |
$16,259 |
|
6/16/2026
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$18.3 |
$2,658 |
|
6/8/2026
|
Buy |
Posner, Brian S. |
Director |
$16.9 |
$33,880 |
|
6/3/2026
|
Buy |
Posner, Brian S. |
Director |
$17.5 |
$43,700 |
|
5/26/2026
|
Buy |
Posner, Brian S. |
Director |
$18.2 |
$36,420 |
|
5/20/2026
|
Buy |
Posner, Brian S. |
Director |
$17.1 |
$42,800 |
|
5/13/2026
|
Sell |
Cox, John |
CEO & President |
$18.4 |
$60,790 |
|
5/13/2026
|
Sell |
Lucera, Erick |
Chief Financial Officer |
$18.4 |
$26,585 |
|
5/13/2026
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$18.4 |
$28,715 |
|
5/13/2026
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$18.4 |
$4,186 |
|
5/6/2026
|
Sell |
Rhodes, Jason P. |
Director |
$18.2 |
$1,512,922 |
|
5/5/2026
|
Sell |
Rhodes, Jason P. |
Director |
$18.0 |
$209,148 |
|
5/4/2026
|
Sell |
Rhodes, Jason P. |
Director |
$18.0 |
$214,272 |
|
4/28/2026
|
Sell |
Rhodes, Jason P. |
Director |
$18.7 |
$4,178,517 |
|
4/27/2026
|
Sell |
Rhodes, Jason P. |
Director |
$18.2 |
$3,148,897 |
|
4/24/2026
|
Sell |
Rhodes, Jason P. |
Director |
$18.5 |
$2,549,280 |
|
4/23/2026
|
Sell |
Rhodes, Jason P. |
Director |
$19.2 |
$1,402,943 |
|
4/22/2026
|
Sell |
Kersten, Dirk |
Director |
$20.0 |
$53,049 |
|
4/22/2026
|
Sell |
Rhodes, Jason P. |
Director |
$19.7 |
$5,666,975 |
|
4/21/2026
|
Sell |
Kersten, Dirk |
Director |
$20.0 |
$166,120 |
|
4/21/2026
|
Sell |
Rhodes, Jason P. |
Director |
$19.8 |
$5,353,110 |
|
4/20/2026
|
Sell |
Kersten, Dirk |
Director |
$20.1 |
$2,513,898 |
|
4/20/2026
|
Sell |
Rhodes, Jason P. |
Director |
$20.1 |
$5,457,303 |
|
4/17/2026
|
Sell |
Kersten, Dirk |
Director |
$20.3 |
$4,301,292 |
|
4/16/2026
|
Sell |
Kersten, Dirk |
Director |
$20.6 |
$368,114 |
|
4/15/2026
|
Sell |
Kersten, Dirk |
Director |
$20.3 |
$1,659,044 |
|
4/1/2026
|
Sell |
Lucera, Erick |
Chief Financial Officer |
$18.6 |
$106,751 |
|
3/30/2026
|
Buy |
Posner, Brian S. |
Director |
$17.1 |
$34,160 |
|
3/11/2026
|
Sell |
Kersten, Dirk |
Director |
$19.5 |
$2,530,562 |
|
3/11/2026
|
Buy |
Posner, Brian S. |
Director |
$19.4 |
$38,700 |
|
3/10/2026
|
Sell |
Kersten, Dirk |
Director |
$19.1 |
$10,000,327 |
|
3/9/2026
|
Sell |
Kersten, Dirk |
Director |
$17.7 |
$3,148,987 |
|
3/6/2026
|
Buy |
Posner, Brian S. |
Director |
$15.1 |
$45,180 |
|
3/5/2026
|
Sell |
Cox, John |
CEO & President |
$14.9 |
$40,707 |
|
3/5/2026
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$14.9 |
$13,470 |
|
3/5/2026
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$14.9 |
$2,205 |
|
12/5/2025
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$20.7 |
$2,984 |
|
12/5/2025
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$20.7 |
$18,234 |
|
12/5/2025
|
Sell |
Cox, John |
CEO & President |
$20.7 |
$55,157 |
|
9/5/2025
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$13.4 |
$11,707 |
|
9/5/2025
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$13.4 |
$1,931 |
|
9/5/2025
|
Sell |
Cox, John |
CEO & President |
$13.4 |
$35,402 |
|
9/4/2025
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$13.3 |
$47,135 |
|
9/4/2025
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$13.3 |
$11,863 |
|
7/14/2025
|
Buy |
Cox, John |
CEO & President |
$9.1 |
$911,000 |
|
6/5/2025
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$13.4 |
$1,949 |
|
6/5/2025
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$13.4 |
$17,916 |
|
6/5/2025
|
Sell |
Cox, John |
CEO & President |
$13.4 |
$54,201 |
|
3/13/2025
|
Sell |
Friedl-Naderer, Johanna |
Chief Commercial Officer |
$12.1 |
$1,733 |
|
3/11/2025
|
Sell |
Beskrovnaya, Oxana |
Chief Scientific Officer |
$11.4 |
$24,501 |
|
3/11/2025
|
Sell |
Scalzo, Richard William |
SVP, Head of Finance & Admin. |
$11.4 |
$15,283 |
|
3/5/2025
|
Sell |
Beskrovnaya, Oxana |
Chief Scientific Officer |
$11.8 |
$12,942 |
|
3/5/2025
|
Sell |
Scalzo, Richard William |
SVP, Head of Finance & Admin. |
$11.8 |
$10,848 |
|
3/5/2025
|
Sell |
Cox, John |
CEO & President |
$11.8 |
$48,042 |
|
3/5/2025
|
Sell |
Kerr, Douglas |
Chief Medical Officer |
$11.8 |
$15,888 |
|
2/18/2025
|
Sell |
Scalzo, Richard William |
SVP, Head of Finance & Admin. |
$14.0 |
$34,708 |
|
2/18/2025
|
Sell |
Beskrovnaya, Oxana |
Chief Scientific Officer |
$14.0 |
$36,242 |
|
12/11/2024
|
Sell |
Scalzo, Richard William |
SVP, Head of Finance & Admin. |
$28.1 |
$40,915 |
|
12/11/2024
|
Sell |
Beskrovnaya, Oxana |
Chief Scientific Officer |
$28.1 |
$65,632 |
|
12/9/2024
|
Sell |
Kersten, Dirk |
Director |
$29.2 |
$1,004,872 |
|
12/6/2024
|
Sell |
Kersten, Dirk |
Director |
$29.3 |
$2,983,145 |
|
12/5/2024
|
Sell |
Kersten, Dirk |
Director |
$29.0 |
$110,564 |
|
12/4/2024
|
Sell |
Kersten, Dirk |
Director |
$29.4 |
$3,968,796 |
|
12/3/2024
|
Sell |
Kersten, Dirk |
Director |
$29.0 |
$863,715 |
|
12/2/2024
|
Sell |
Kersten, Dirk |
Director |
$30.0 |
$2,409,293 |
|
11/18/2024
|
Sell |
Beskrovnaya, Oxana |
Chief Scientific Officer |
$28.2 |
$80,539 |
|
11/18/2024
|
Sell |
Scalzo, Richard William |
SVP, Head of Finance & Admin. |
$28.2 |
$77,127 |
|
11/18/2024
|
Sell |
Incerti, Carlo |
Director |
$28.7 |
$474,045 |
|
11/14/2024
|
Sell |
Kersten, Dirk |
Director |
$32.8 |
$293,050 |
|
11/14/2024
|
Sell |
Rhodes, Jason P. |
Director |
$33.1 |
$25,883 |
|
11/13/2024
|
Sell |
Kersten, Dirk |
Director |
$35.2 |
$380,698 |
|
10/21/2024
|
Sell |
Kersten, Dirk |
Director |
$35.1 |
$4,242 |
|
10/18/2024
|
Sell |
Kersten, Dirk |
Director |
$35.2 |
$471,636 |
|
10/17/2024
|
Sell |
Kersten, Dirk |
Director |
$35.2 |
$457,667 |
|
10/16/2024
|
Sell |
Kersten, Dirk |
Director |
$35.4 |
$836,770 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now